Throughout the COVID-19 pandemic, Saint Luke’s Health System is committed to providing exceptional care for all patients and a safe and healthy atmosphere for our team.

In heart transplant recipients, PCSK9 inhibitors lowered LDL, stabilized coronary intimal hyperplasia and were associated with minimal adverse effects, according to data from the virtual Heart Failure Society of America Scientific Meeting.

Yasser Sammour, MD, internal medicine resident at Saint Luke’s Mid-America Heart Institute, and colleagues analyzed 68 patients from Saint Luke’s who received a heart transplant from 1999 to 2019 and were prescribed a PCSK9 inhibitor after the transplant.

Read the full article about the findings: Healio: PCSK9 inhibitors safe, effective in patients with heart transplants

Read more >

Related Content

Person, Doctor, Clothing, Apparel, Lab Coat, Coat, Face, Nurse
Deb's story

Deb Day, Registered Nurse · Anderson County Hospital I am a Saint Luke's Nurse The room to grow, the tools to succeed Nurses are the lifeblood of Saint Luke’s compassionate...

Read more >
Apparel, Clothing, Coat, Lab Coat, Person, Doctor
Danielle's story

"You get those rare moments that you're reminded why you went into this field, and it makes everything so much better." Danielle Hammontree, Certified Family Nurse PractitionerSaint Luke’s East Hospital

Read more >
Person, Text, Female, Clothing, Apparel, Worker, Woman
Brenda's story

"We were able to sustain her long enough so she could make that closure with her family." Brenda Messer, Registered NurseSaint Luke’s Hospital of Kansas City

Read more >